Tuberculosis Interferon Gamma Release Assay - India CDSCO Medical Device Registration
Tuberculosis Interferon Gamma Release Assay is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000060_126091e08a4fa3cd7536f3f62f099f43_37e2a5eca4c82a180bc32e60121b0829. This device is marketed under the brand name EIA. The license holder is Genomix Molecular Diagnostics Pvt Ltd, and it is classified as Device Class Class B. The approving authority is Telangana.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Brand Name
EIA
License Holder
Genomix Molecular Diagnostics Pvt LtdDevice Class
Approving Authority
Telangana
Product Information
For quantitative detection of Interferon Gamma (EIA) that respond to in-vitro stimulation by M. tuberculosis antigens in whole blood. It is intended for use as an aid in the diagnosis of tuberculosis (EIA) infection
Bovine Leptospira Antibody indirect ELISA test Kit
Rhodococcus Antibody Rapid Test Kit
Theileria Ta/To Antibody Rapid Test Kit
Classical Swine Fever Antibody Rapid Test Kit
Leptospira Antibody ELISA Test Kit
EIA Antibody Rapid Test Kit
Campylobacter Antibody Rapid Test Kit
Glanders Antibody detection Rapid Test Kit
Chikungunya virus IgM Antibody ELISA test Kit
Anti-Mullerian Hormone ELISA test Kit
Brand: EIA